Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
作者: Ke ChenWeikun QianZhengdong JiangLiang ChengJie LiLiankang SunCancan ZhouLuping GaoMeng LeiBin YanJunyu CaoWanxing DuanQingyong Ma
作者单位: 1First Affiliated Hospital, Xi’an Jiaotong University
刊名: Molecular Cancer, 2017, Vol.16 (1)
来源数据库: Springer Nature Journal
DOI: 10.1186/s12943-017-0701-0
关键词: MetforminPancreatic cancerTumorigenesisChronic pancreatitis
原始语种摘要: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-associated mortality worldwide with an overall five-year survival rate less than 7%. Accumulating evidence has revealed the cancer preventive and therapeutic effects of metformin, one of the most widely prescribed medications for type 2 diabetes mellitus. However, its role in pancreatic cancer is not fully elucidated. Herein, we aimed to further study the preventive and therapeutic effects of metformin in genetically engineered mouse models of pancreatic cancer.
全文获取路径: Springer Nature  (合作)
影响因子:5.134 (2012)

  • pancreatic 胰的
  • metformin 二甲双胍
  • cancer 癌症
  • pancreatitis 胰脏炎
  • diabetes 糖尿病
  • mouse 小鼠
  • preventive 预防性
  • therapeutic 治疗的
  • progression 级数
  • adenocarcinoma 腺癌